Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Selvas Healthcare Inc. (208370:KRX), powered by AI.
Selvas Healthcare Inc. is currently trading at ₩4,315. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Selvas Healthcare Inc. on Alpha Lenz.
Selvas Healthcare Inc.'s P/E ratio is 35.2.
“Selvas Healthcare Inc. trades at a P/E of 35.2 (premium valuation) with modest ROE of 5.1%.”
Ask for details →Selvas Healthcare Inc. is a prominent player in the healthcare technology sector, specializing in the development and manufacture of cutting-edge medical equipment and solutions. The company's primary aim is to enhance clinical accuracy and streamline healthcare delivery by integrating advanced technologies into their products. Notable offerings from Selvas Healthcare include sophisticated diagnostic devices, innovation-driven therapeutic tools, and patient-care systems designed to improve efficiency and outcomes in medical settings. The company has built a reputation for leveraging artificial intelligence and data analytics within their equipment, thus providing crucial support across various medical specialties, including cardiology, radiology, and general diagnostics. Headquartered in a tech-savvy region, Selvas Healthcare contributes significantly to the advancement of healthcare technology, influencing both domestic and international markets. Its products play a pivotal role in improving not only patient care but also operational efficiency in healthcare facilities, marking its significance in the ongoing evolution of the medical services industry.
“Selvas Healthcare Inc. trades at a P/E of 35.2 (premium valuation) with modest ROE of 5.1%.”
Ask for details →Selvas Healthcare Inc. (ticker: 208370) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 128 employees. Market cap is $111.1B.
The current price is ₩4,315 with a P/E ratio of 35.18x and P/B of 1.74x.
ROE is 5.09% and operating margin is 10.33%. Annual revenue is $31.7B.